ESICM News

What's new with our Clinical Trials?

What's new with our Clinical Trials?

LUNG-SAFE ~ Southern Hemisphere: Register now for LUNG-SAFE, a Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE. This study aims to provide new and current data on the disease burden of acute hypoxemic respiratory failure and ARDS. The first phase in the Northern Hemisphere is now complete, and investigators are eager to replicate the success in phase two. Registered centres from the Southern Hemisphere are asked to enrol patients during a four-week period from June 1st to August 31st. For more details, visit the LUNG-SAFE webpage.



IC-GLOSSARI  (The Intensive Care GLObal Study on Severe Acute Respiratory Infection) ~ This multicentre study investigating the epidemiology and microbiology profiles of ICU-SARI is currently concluding the validation process.

REMINDER: Registered participants with patients enrolled in this study who have yet to be validated, should ensure that this is complete as soon as possible. Find out more about this exciting Global study here: IC-GLOSSARI.

For more information about all of our Clinical Trials click below.

<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)